Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Immune-Checkpoint Blockade Opposes CD8+ T-Cell Suppression in Human and Murine Cancer.

Pfannenstiel LW, Diaz-Montero M, Tian YF, Scharpf J, Ko J, Gastman B.

Cancer Immunol Res. 2019 Feb 6. pii: canimm.0054.2018. doi: 10.1158/2326-6066.CIR-18-0054. [Epub ahead of print]

PMID:
30728151
2.

Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck.

Gastman BR, Zager JS, Messina JL, Cook RW, Covington KR, Middlebrook B, Gerami P, Wayne JD, Leachman S, Vetto JT.

Head Neck. 2019 Jan 29. doi: 10.1002/hed.25473. [Epub ahead of print]

PMID:
30694001
3.

Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling.

Vetto JT, Hsueh EC, Gastman BR, Dillon LD, Monzon FA, Cook RW, Keller J, Huang X, Fleming A, Hewgley P, Gerami P, Leachman S, Wayne JD, Berger AC, Fleming MD.

Future Oncol. 2019 Jan 29. doi: 10.2217/fon-2018-0912. [Epub ahead of print]

4.

Face Transplantation for Granulomatosis With Polyangiitis (Wegener Granulomatosis): Technical Considerations, Immunological Aspects, and 3-Year Posttransplant Outcome.

Hashem AM, Djohan R, Bernard S, Hendrickson M, Schwarz G, Gharb BB, Rampazzo A, Hoffman GS, Doumit G, Bergfeld W, Zins JE, Siemionow M, Papay F, Gastman B.

Ann Plast Surg. 2019 Mar;82(3):320-329. doi: 10.1097/SAP.0000000000001735.

PMID:
30633023
5.

THE TIMING OF ALLOPLASTIC CRANIOPLASTY IN THE SETTING OF PREVIOUS OSTEOMYELITIS.

Kwiecien GJ, Aliotta R, Gharb BB, Gastman B, Zins JE.

Plast Reconstr Surg. 2018 Dec 26. doi: 10.1097/PRS.0000000000005363. [Epub ahead of print]

PMID:
30601322
6.

Reply to "Use of a prognostic gene expression profile test for T1 cutaneous melanoma: will it help or harm patients?"

Gastman BR, Cook RW.

J Am Acad Dermatol. 2018 Dec 23. pii: S0190-9622(18)33105-0. doi: 10.1016/j.jaad.2018.12.032. [Epub ahead of print] No abstract available.

PMID:
30586615
7.

IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells.

Chen X, Cai G, Liu C, Zhao J, Gu C, Wu L, Hamilton TA, Zhang CJ, Ko J, Zhu L, Qin J, Vidimos A, Koyfman S, Gastman BR, Jensen KB, Li X.

J Exp Med. 2019 Jan 7;216(1):195-214. doi: 10.1084/jem.20171849. Epub 2018 Dec 21.

PMID:
30578323
8.

Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8+ T cells from negative regulation by local IFN-γ.

Lin L, Rayman P, Pavicic PG Jr, Tannenbaum C, Hamilton T, Montero A, Ko J, Gastman B, Finke J, Ernstoff M, Diaz-Montero CM.

Cancer Immunol Immunother. 2018 Dec 14. doi: 10.1007/s00262-018-2280-3. [Epub ahead of print]

PMID:
30552459
9.

Histopathologic correlation of high-risk MelaFindTM lesions: a 3-year experience from a high-risk pigmented lesion clinic.

Shrivastava V, Bailin P, Elliott J, Bacnik E, Gastman B, Bergfeld W, Billings SD, Piliang M, Fernandez A, Kovalyshyn I, Ko JS.

Int J Dermatol. 2018 Dec 13. doi: 10.1111/ijd.14336. [Epub ahead of print]

PMID:
30549001
10.

Combination PD-1 blockade and irradiation of brain metastasis induces an effective abscopal effect in melanoma.

Pfannenstiel LW, McNeilly C, Xiang C, Kang K, Diaz-Montero CM, Yu JS, Gastman BR.

Oncoimmunology. 2018 Oct 11;8(1):e1507669. doi: 10.1080/2162402X.2018.1507669. eCollection 2019.

PMID:
30546944
11.

Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer.

Knackstedt RW, Knackstedt T, Gastman B.

J Surg Res. 2018 Dec;232:365-368. doi: 10.1016/j.jss.2018.06.070. Epub 2018 Jul 18.

PMID:
30463742
12.

Gene expression profiling in melanoma: past results and future potential.

Knackstedt RW, Knackstedt T, Gastman B.

Future Oncol. 2018 Nov 20. doi: 10.2217/fon-2018-0631. [Epub ahead of print]

PMID:
30453756
13.

Decreased T-Cell Programmed Death Receptor-1 Expression in Pregnancy-Associated Melanoma.

Ko JS, Gastman BR, Conic R, Tellez Diaz Trujillo A, Diaz-Montero CM, Billings SD, Tarhini A, Funchain P, Atanaskova Mesinkovska N.

Am J Dermatopathol. 2018 Oct 9. doi: 10.1097/DAD.0000000000001286. [Epub ahead of print]

PMID:
30308543
14.

Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.

Varra V, Woody NM, Reddy C, Joshi NP, Geiger J, Adelstein DJ, Burkey BB, Scharpf J, Prendes B, Lamarre ED, Lorenz R, Gastman B, Manyam BV, Koyfman SA.

Anticancer Res. 2018 Oct;38(10):5825-5830. doi: 10.21873/anticanres.12923.

PMID:
30275206
15.

Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.

Conic RRZ, Ko J, Damiani G, Funchain P, Knackstedt T, Vij A, Vidimos A, Gastman BR.

J Am Acad Dermatol. 2019 Feb;80(2):441-447. doi: 10.1016/j.jaad.2018.08.051. Epub 2018 Sep 18.

PMID:
30240775
16.

Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria.

Gastman BR, Gerami P, Kurley SJ, Cook RW, Leachman S, Vetto JT.

J Am Acad Dermatol. 2019 Jan;80(1):149-157.e4. doi: 10.1016/j.jaad.2018.07.028. Epub 2018 Aug 4.

17.

Long-term Outcomes of Cranioplasty: Titanium Mesh Is Not a Long-term Solution in High-risk Patients.

Kwiecien GJ, Rueda S, Couto RA, Hashem A, Nagel S, Schwarz GS, Zins JE, Gastman BR.

Ann Plast Surg. 2018 Oct;81(4):416-422. doi: 10.1097/SAP.0000000000001559.

PMID:
30059381
18.

Malignant Melanoma: Diagnostic and Management Update.

Knackstedt T, Knackstedt RW, Couto R, Gastman B.

Plast Reconstr Surg. 2018 Aug;142(2):202e-216e. doi: 10.1097/PRS.0000000000004571. Review.

PMID:
30045186
19.

Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in head and neck melanoma.

Knackstedt RW, Couto RA, Gastman B.

J Surg Res. 2018 Aug;228:77-83. doi: 10.1016/j.jss.2018.02.064. Epub 2018 Mar 26.

PMID:
29907233
20.

Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Blitzblau R, Bowen GM, Contreras CM, Daniels GA, Decker R, Farma JM, Fisher K, Gastman B, Ghosh K, Grekin RC, Grossman K, Ho AL, Lewis KD, Loss M, Lydiatt DD, Messina J, Nehal KS, Nghiem P, Puzanov I, Schmults CD, Shaha AR, Thomas V, Xu YG, Zic JA, Hoffmann KG, Engh AM.

J Natl Compr Canc Netw. 2018 Jun;16(6):742-774. doi: 10.6004/jnccn.2018.0055.

PMID:
29891526
21.

Reply to: "Comment on 'Determination of the impact of melanoma surgical timing on survival using the National Cancer Database'".

Conic RRZ, Gastman BR.

J Am Acad Dermatol. 2018 Oct;79(4):e73-e74. doi: 10.1016/j.jaad.2018.05.042. Epub 2018 May 31. No abstract available.

PMID:
29860045
22.

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0.

Sullivan RJ, Atkins MB, Kirkwood JM, Agarwala SS, Clark JI, Ernstoff MS, Fecher L, Gajewski TF, Gastman B, Lawson DH, Lutzky J, McDermott DF, Margolin KA, Mehnert JM, Pavlick AC, Richards JM, Rubin KM, Sharfman W, Silverstein S, Slingluff CL Jr, Sondak VK, Tarhini AA, Thompson JA, Urba WJ, White RL, Whitman ED, Hodi FS, Kaufman HL.

J Immunother Cancer. 2018 May 30;6(1):44. doi: 10.1186/s40425-018-0362-6.

23.

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.

Sun L, Funchain P, Song JM, Rayman P, Tannenbaum C, Ko J, Mcnamara M, Marcela Diaz-Montero C, Gastman B.

J Immunother Cancer. 2018 May 16;6(1):36. doi: 10.1186/s40425-018-0337-7.

24.

Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.

Stiegel E, Xiong D, Ya J, Funchain P, Isakov R, Gastman B, Vij A.

J Am Acad Dermatol. 2018 May;78(5):942-948. doi: 10.1016/j.jaad.2018.01.030. Epub 2018 Jan 31.

PMID:
29408526
25.

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.

Zager JS, Gastman BR, Leachman S, Gonzalez RC, Fleming MD, Ferris LK, Ho J, Miller AR, Cook RW, Covington KR, Meldi-Plasseraud K, Middlebrook B, Kaminester LH, Greisinger A, Estrada SI, Pariser DM, Cranmer LD, Messina JL, Vetto JT, Wayne JD, Delman KA, Lawson DH, Gerami P.

BMC Cancer. 2018 Feb 5;18(1):130. doi: 10.1186/s12885-018-4016-3.

26.

Determination of the impact of melanoma surgical timing on survival using the National Cancer Database.

Conic RZ, Cabrera CI, Khorana AA, Gastman BR.

J Am Acad Dermatol. 2018 Jan;78(1):40-46.e7. doi: 10.1016/j.jaad.2017.08.039. Epub 2017 Oct 17.

27.

Mixed Versus Pure Variants of Desmoplastic Melanoma: The Cleveland Clinic Experience.

Conic RZ, Ko J, Allam SH, Atanaskova-Mesinkovska N, Kovalyshyn I, Bergfeld W, Gastman BR.

Ann Plast Surg. 2018 Mar;80(3):277-281. doi: 10.1097/SAP.0000000000001225.

PMID:
28984655
28.

Determining the False-Negative Rate Using Fluorescence Image-Assisted Sentinel Lymph Node Biopsy in Cutaneous Melanoma.

Couto RA, Lamaris GA, Knackstedt R, Alleyne B, Durand P, Rueda S, Gastman B.

Ann Plast Surg. 2018 Jan;80(1):54-58. doi: 10.1097/SAP.0000000000001211.

PMID:
28930782
29.

Tumor-derived exosomes induce CD8+ T cell suppressors.

Maybruck BT, Pfannenstiel LW, Diaz-Montero M, Gastman BR.

J Immunother Cancer. 2017 Aug 15;5(1):65. doi: 10.1186/s40425-017-0269-7.

30.

Single-stage versus two-stage arteriovenous loop microsurgical reconstruction: A meta-analysis of the literature.

Knackstedt R, Aliotta R, Gatherwright J, Djohan R, Gastman B, Schwarz G, Hendrickson M, Gurunluoglu R.

Microsurgery. 2018 Sep;38(6):706-717. doi: 10.1002/micr.30204. Epub 2017 Jul 24. Review.

PMID:
28738446
31.

Identification of Risk Factors in Lymphatic Surgeries for Melanoma: A National Surgical Quality Improvement Program Review.

Ascha M, Ascha MS, Gastman B.

Ann Plast Surg. 2017 Nov;79(5):509-515. doi: 10.1097/SAP.0000000000001152.

PMID:
28650410
32.

Total Abdominal Wall Transplantation: An Anatomical Study and Classification System.

Light D, Kundu N, Djohan R, Quintini C, Gandhi N, Gastman BR, Drake R, Siemionow M, Zins JE.

Plast Reconstr Surg. 2017 Jun;139(6):1466-1473. doi: 10.1097/PRS.0000000000003327.

PMID:
28538578
33.

Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence.

Demelash A, Pfannenstiel LW, Liu L, Gastman BR.

Oncotarget. 2017 Apr 25;8(17):28154-28168. doi: 10.18632/oncotarget.15962.

34.

Watershed Areas in Face Transplantation.

Bassiri Gharb B, Frautschi RS, Halasa BC, Doumit GD, Djohan RS, Bernard SL, Gastman BR, Siemionow MZ, Papay FA, Rampazzo A.

Plast Reconstr Surg. 2017 Mar;139(3):711-721. doi: 10.1097/PRS.0000000000003130. Review.

PMID:
28234852
35.

A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.

Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom SS, Nussenbaum B, Wang SJ, Vidimos AT, Koyfman SA.

Cancer. 2017 Jun 1;123(11):2054-2060. doi: 10.1002/cncr.30601. Epub 2017 Feb 7.

36.

The Anterolateral Thigh Flap as the Flap of Choice for Scalp Reconstruction.

Lamaris GA, Knackstedt R, Couto RA, Abedi N, Durand P, Gastman B.

J Craniofac Surg. 2017 Mar;28(2):472-476. doi: 10.1097/SCS.0000000000003404.

PMID:
28114212
37.

Tolerability of immune checkpoint inhibition cancer therapy in a cardiac transplant patient.

Gastman BR, Ernstoff MS.

Ann Oncol. 2016 Dec;27(12):2304-2305. doi: 10.1093/annonc/mdw293. Epub 2016 Aug 8. No abstract available.

PMID:
27502714
38.

NCCN Guidelines Insights: Melanoma, Version 3.2016.

Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Fields RC, Fleming MD, Gastman B, Gonzalez R, Guild V, Johnson D, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A.

J Natl Compr Canc Netw. 2016 Aug;14(8):945-58.

PMID:
27496110
39.

Malignant Pyoderma Associated with Granulomatosis with Polyangiitis (Wegener Granulomatosis) as a Unique Indication for Facial Vascularized Composite Allotransplantation: Part I.

Gastman B, Hashem AM, Djohan R, Bernard S, Hendrickson M, Schwarz G, Gharb BB, Rampazzo A, Fernandez A, Zins J, Hoffman GS, Doumit G, Siemionow M, Papay F.

Plast Reconstr Surg. 2016 Jun;137(6):1007e-15e. doi: 10.1097/PRS.0000000000002162.

PMID:
27219252
40.

Management of Conjunctival Melanoma: Critical Assessment of Sentinel Lymph Node Biopsy.

Aziz HA, Gastman BR, Singh AD.

Ocul Oncol Pathol. 2015 Jun;1(4):266-73. doi: 10.1159/000381719. Epub 2015 May 6.

41.

The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons.

Sha J, Gastman BR, Morris N, Mesinkovska NA, Baron ED, Cooper KD, McCormick T, Arbesman J, Harter ML.

PLoS One. 2016 May 5;11(5):e0154915. doi: 10.1371/journal.pone.0154915. eCollection 2016.

42.

Establishing the Feasibility of Face Transplantation in Granulomatosis With Polyangiitis.

Hashem AM, Hoffman GS, Gastman B, Bernard S, Djohan R, Hendrickson M, Schwarz G, Doumit G, Gharb BB, Rampazzo A, Zins JE, Siemionow M, Papay F.

Am J Transplant. 2016 Jul;16(7):2213-2223. doi: 10.1111/ajt.13751. Epub 2016 Apr 8.

43.

Risk factors and outcomes of cutaneous melanoma in women less than 50 years of age.

Tellez A, Rueda S, Conic RZ, Powers K, Galdyn I, Mesinkovska NA, Gastman B.

J Am Acad Dermatol. 2016 Apr;74(4):731-8. doi: 10.1016/j.jaad.2015.11.014. Epub 2016 Jan 20.

PMID:
26803345
44.

Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients.

Ko JS, Prieto VG, Elson PJ, Vilain RE, Pulitzer MP, Scolyer RA, Reynolds JP, Piliang MP, Ernstoff MS, Gastman BR, Billings SD.

Mod Pathol. 2016 Feb;29(2):122-30. doi: 10.1038/modpathol.2015.109. Epub 2015 Nov 6.

45.

Periocular Skin Cancer in Solid Organ Transplant Recipients.

Perry JD, Polito SC, Chundury RV, Singh AD, Fritz MA, Vidimos AT, Gastman BR, Koyfman SA.

Ophthalmology. 2016 Jan;123(1):203-8. doi: 10.1016/j.ophtha.2015.09.030. Epub 2015 Oct 29.

PMID:
26520170
46.

A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis.

Wu L, Chen X, Zhao J, Martin B, Zepp JA, Ko JS, Gu C, Cai G, Ouyang W, Sen G, Stark GR, Su B, Vines CM, Tournier C, Hamilton TA, Vidimos A, Gastman B, Liu C, Li X.

J Exp Med. 2015 Sep 21;212(10):1571-87. doi: 10.1084/jem.20150204. Epub 2015 Sep 7.

47.

Structure-Function Analysis of the Mcl-1 Protein Identifies a Novel Senescence-regulating Domain.

Demelash A, Pfannenstiel LW, Tannenbaum CS, Li X, Kalady MF, DeVecchio J, Gastman BR.

J Biol Chem. 2015 Sep 4;290(36):21962-75. doi: 10.1074/jbc.M115.663898. Epub 2015 Jul 23.

48.

Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.

Manyam BV, Gastman B, Zhang AY, Reddy CA, Burkey BB, Scharpf J, Alam DS, Fritz MA, Vidimos AT, Koyfman SA.

J Am Acad Dermatol. 2015 Aug;73(2):221-7. doi: 10.1016/j.jaad.2015.04.037. Epub 2015 May 29.

PMID:
26028524
49.

Superior epigastric artery perforator (SEAP) flap: a novel approach to autologous breast reconstruction.

Kundu N, Chopra K, Morales R, Djohan R, Chung T, Gastman BR.

J Plast Reconstr Aesthet Surg. 2015 Apr;68(4):519-24. doi: 10.1016/j.bjps.2014.12.006. Epub 2014 Dec 18.

PMID:
25582506
50.

Mcl-1 and tumor cell persistence.

Pfannenstiel LW, Gastman BR.

Oncotarget. 2015 Jan 1;6(1):5-6. No abstract available.

Supplemental Content

Loading ...
Support Center